Otros recursos con las palabras clave Genetics

Resultados 1 - 10 de 23.050 de Genetics. (0,05 segundos)


Documentos:
  1. Common Genetic Variation in the 3 '-BCL11B Gene Desert Is Associated With Carotid-Femoral Pulse Wave Velocity and Excess Cardiovascular Disease Risk The AortaGen Consortium (�)

    Mitchell, GF; Verwoert, GC; Tarasov, KV; Isaacs, A; Smith, AV; Yasmin,; Rietzschel, ER; Tanaka, T; Liu, Y; Parsa, A; Najjar, SS; O'Shaughnessy, KM; Sigurdsson, S; De Buyzere, ML; Larson, MG; Sie, MPS; Andrews, JS; Post, WS; Mattace-Raso, FUS; McEniery, CM; Eiriksdottir, G; Segers, P; Vasan, RS; van Rijn, MJE; Howard, TD; McArdle, PF; Dehghan, A; Jewell, ES; Newhouse, SJ; Bekaert, S; Hamburg, NM; Newman, AB; Hofman, A; Scuteri, A; De Bacquer, D; Ikram, MA; Psaty, BM; Fuchsberger, C; Olden, M; Wain, LV; Elliott, P; Smith, NL; Felix, JF; Erdmann, J; Vita, JA; Sutton-Tyrrell, K; Sijbrands, EJG; Sanna, S; Launer, LJ; De Meyer, T; Johnson, AD; Schut, AFC; Herrington, DM; Rivadeneira, F; Uda, M; Wilkinson, IB; Aspelund, T; Gillebert, TC; Van Bortel, L; Benjamin, EJ; Oostra, BA; Ding, J; Gibson, Q; Uitterlinden, AG; Abecasis, GR; Cockcroft, JR; Gudnason, V; De Backer, GG; Ferrucci, L; Harris, TB; Shuldiner, AR; van Duijn, CM; Levy, D; Lakatta, EG; Witteman, JCM
    29-may-2017

  2. Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's disease. (�)

    Brown, BM; Sohrabi, HR; Taddei, K; Gardener, SL; Rainey-Smith, SR; Peiffer, JJ; Xiong, C; Fagan, AM; Benzinger, T; Buckles, V; Erickson, KI; Clarnette, R; Shah, T; Masters, CL; Weiner, M; Cairns, N; Rossor, M; Graff-Radford, NR; Salloway, S; Vöglein, J; Laske, C; Noble, J; Schofield, PR; Bateman, RJ; Morris, JC; Martins, RN; Dominantly Inherited Alzheimer Network,
    INTRODUCTION: The objective of this study was to evaluate the relationship between self-reported exe ...
    29-may-2017

  3. Genotype-phenotype relationships in Fabry disease: developing an online interactive web-based data collection system (�)

    Qin, C; De Silva, N; Mehta, A; Ramaswami, U; Hughes, D
    29-may-2017

  4. Heterogeneity in Fabry disease (�)

    Lavalle, L; Thomas, A; Beaton, B; Ebrahim, H; Reed, M; Ramaswami, U; Mehta, A; Hughes, D
    29-may-2017

  5. Increase synthesis of collagen type I: an early event in Fabry cardiomyopathy. New biomarkers? (�)

    Aguiar, P; Azevedo, O; Pinto, R; Marino, J; Cardoso, C; Ducla Soares, JL; Hughes, D
    29-may-2017

  6. MicroRNAs in Fabry disease: role as biomarkers and a possible pathophysiological pathway (�)

    Aguiar, P; Costa, MC; Azevedo, O; Fiuza, M; Marino, J; Ducla Soares, JL; Hughes, D; Enguita, FJ
    29-may-2017

  7. Prompt agalsidase alfa therapy initiation after symptom onset is associated with improved renal and cardiovascular outcomes in the Fabry Outcome Survey (�)

    Linhart, A; Hughes, D; Gurevich, A; Joseph, A; Kerstens, R; Feriozzi, S
    29-may-2017

  8. PRX-102 for treating Fabry disease: immunogenicity and PK results from a phase 1-2 study (�)

    Warnock, D; Hughes, D; Boyd, S; Giraldo, P; Gonzalez, D; Holida, M; Goker-Alpan, O; Maegawa, G; Atta, M; Nicholls, K; Schiffmann, R; Tuffaha, A; Charney, M; Chertkoff, R; Alon, S; Brill-Almon, E
    29-may-2017

  9. The role of mesenchymal stem cells in the development of bone pathology and myeloma in Gaucher disease (�)

    Beaton, B; Reed, M; Hughes, DA
    29-may-2017

  10. Adjuvant oral salbutamol in treatment of juvenile Pompe disease: novel outcome assessment tool and initial report one-year efficacy in single case (�)

    Wood, M; Gissen, P; Davison, JE
    29-may-2017

Aviso de cookies: Usamos cookies propias y de terceros para mejorar nuestros servicios, para análisis estadístico y para mostrarle publicidad. Si continua navegando consideramos que acepta su uso en los términos establecidos en la Política de cookies.